My primary expertise is in functional genomics, utilizing CRISPR/Cas9 and lentiviral vectors. I employ CRISPR-based genome screening to investigate innate immune regulation, cellular responses to viral infections, and mechanisms of diffuse large B-cell lymphoma. Additionally, I work on delivering CRISPR/Cas9 systems via virus-like particles for therapeutic applications.